[go: up one dir, main page]

IT1247796B - Derivati arilvinilamidici e procedimento per la loro preparazione - Google Patents

Derivati arilvinilamidici e procedimento per la loro preparazione

Info

Publication number
IT1247796B
IT1247796B ITMI910080A ITMI910080A IT1247796B IT 1247796 B IT1247796 B IT 1247796B IT MI910080 A ITMI910080 A IT MI910080A IT MI910080 A ITMI910080 A IT MI910080A IT 1247796 B IT1247796 B IT 1247796B
Authority
IT
Italy
Prior art keywords
derivatives
arylvylamide
procedure
preparation
arylvinylamide
Prior art date
Application number
ITMI910080A
Other languages
English (en)
Inventor
Franco Buzzetti
Angelo Crugnola
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ITMI910080A0 publication Critical patent/ITMI910080A0/it
Publication of ITMI910080A1 publication Critical patent/ITMI910080A1/it
Application granted granted Critical
Publication of IT1247796B publication Critical patent/IT1247796B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Oggetto dell'invenzione sono nuovi derivati arilvinilamidici utili come inibitori della tirosina-chinasi.
ITMI910080A 1990-01-16 1991-01-15 Derivati arilvinilamidici e procedimento per la loro preparazione IT1247796B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909000950A GB9000950D0 (en) 1990-01-16 1990-01-16 New arylvinylamide derivatives and process for their preparation

Publications (3)

Publication Number Publication Date
ITMI910080A0 ITMI910080A0 (it) 1991-01-15
ITMI910080A1 ITMI910080A1 (it) 1992-07-15
IT1247796B true IT1247796B (it) 1995-01-02

Family

ID=10669367

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910080A IT1247796B (it) 1990-01-16 1991-01-15 Derivati arilvinilamidici e procedimento per la loro preparazione

Country Status (6)

Country Link
US (1) US5122537A (it)
JP (1) JPH04210946A (it)
DE (1) DE4039139A1 (it)
FR (1) FR2657081B1 (it)
GB (2) GB9000950D0 (it)
IT (1) IT1247796B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9004483D0 (en) * 1990-02-28 1990-04-25 Erba Carlo Spa New aryl-and heteroarylethenylene derivatives and process for their preparation
US5587385A (en) * 1991-12-24 1996-12-24 Farmitalia Carlo Erba S.R.L. Arylidene-heterocyclic derivatives and process for their preparation
EP0549348A1 (en) * 1991-12-24 1993-06-30 PHARMACIA S.p.A. Arylidene-heterocyclic derivatives, process for their preparation and their use as tyrisine kinase inhibitors
GB9226855D0 (en) * 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation
GB9313638D0 (en) * 1993-07-01 1993-08-18 Erba Carlo Spa Arylidene and heteroarylidene oxindole derivatives and process for their preparation
GB9326136D0 (en) * 1993-12-22 1994-02-23 Erba Carlo Spa Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
WO1995024190A2 (en) * 1994-03-07 1995-09-14 Sugen, Inc. Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
US5696148A (en) * 1994-03-14 1997-12-09 Novo Nordisk A/S Indole compounds and their use in treating diseases of the central nervous system
GB9406137D0 (en) * 1994-03-28 1994-05-18 Erba Carlo Spa N-substituted beta-aryl- and betaheteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
AU760046B2 (en) 1998-02-27 2003-05-08 United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3056790A (en) * 1960-01-08 1962-10-02 Wisconsin Alumni Res Found 8-ro-2-quinoline acrylic acid and lower alkyl esters thereof
DE1902402A1 (de) * 1968-05-21 1969-11-27 Dresden Arzneimittel Verfahren zur Herstellung von 1-substituierten 6.7-Dimethoxy-isochinolinen
JPS6210048A (ja) * 1985-07-04 1987-01-19 Microbial Chem Res Found 新規生理活性物質ｍｈ４３５
US4925877A (en) * 1986-02-25 1990-05-15 Zaidanhojin Biseibutsu Kagaku Kenkyukai Physiologically active erbstatin analogue compounds and compositions
GB8727099D0 (en) * 1987-11-19 1987-12-23 Cellena Cell Eng A G Compositions containing melantonin/homologues

Also Published As

Publication number Publication date
GB9100840D0 (en) 1991-02-27
ITMI910080A1 (it) 1992-07-15
GB2240104A (en) 1991-07-24
GB9000950D0 (en) 1990-03-14
FR2657081B1 (fr) 1992-08-14
US5122537A (en) 1992-06-16
DE4039139A1 (de) 1991-07-18
JPH04210946A (ja) 1992-08-03
FR2657081A1 (fr) 1991-07-19
GB2240104B (en) 1993-08-11
ITMI910080A0 (it) 1991-01-15

Similar Documents

Publication Publication Date Title
MX9204661A (es) Compuestos intermedios derivados de eter y procedimiento para su preparacion.
NO944430D0 (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
TR199800759T2 (xx) Protein Kinaz C �nhibit�r�.
MX9100628A (es) Compuestos peptidomimeticos de borolisina y procedimiento para su preparacion.
NO903589L (no) Fremgangsmaate for flytendegjoering av naturgass.
IT1247796B (it) Derivati arilvinilamidici e procedimento per la loro preparazione
IT1190732B (it) Derivati della 3,4-diidro-5h-2,3-benzodiazepina e procedimento per la loro preparazione
FI894671A0 (fi) Reglerbar faestanordning.
IT1187717B (it) Procedimento per la preparazione di derivati 3-sostituiti dell'1-amino-2-idrossi-propano
ES2162110T3 (es) Derivados de la quinolina antimalaria.
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
IT1164180B (it) Derivati n-carbammoilici dell'isotiazolo-(5,4b)piridin-one-3 e loro procedimento di preparazione
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
IT1233446B (it) Derivati della 3 piperidinocarbaldeide ossima, loro procedimento di preparazione e loro applicazione come farmaci
IT1227456B (it) Nuovi alcossi derivati di ginkgolidi, loro preparazione e composizioni terapeutiche che li contengono
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
IT8320278A0 (it) Derivati delle rifamicine eprocedimento per la loro preparazione.
IT7869504A0 (it) Derivati dell'1-(naftiletil)-imidazolo,particolarmente utili come anticonvulsivi ed antisecretivi,e procedimento per la loro preparazione
DK0790994T3 (da) Heterocyclisk substituerede propensyrederivater som NMDA-antagonister
IT9020092A0 (it) Procedimento per la preparazione di derivati chinazolinici
IT8323010A0 (it) Derivati 15-cicloalifatici di 13,14-dideidro carboprostacicline eprocedimento per la loro preparazione.
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
IT1204912B (it) Derivati del 9,10-diidro fenantrene e procedimento per la loro preparazione
IT1267205B1 (it) Procedimento per la preparazione di derivati della pirrolizina.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960129